A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C-Reference-Cited by-同舟云学术

A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C

Published:2011-06-23 Issue:2 Volume:54 Page:396-405
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Dienstag Jules L.,Ghany Marc G.,Morgan Timothy R.,Di Bisceglie Adrian M.,Bonkovsky Herbert L.,Kim Hae-Young,Seeff Leonard B.,Szabo Gyongyi,Wright Elizabeth C.,Sterling Richard K.,Everson Gregory T.,Lindsay Karen L.,Lee William M.,Lok Anna S.,Morishima Chihiro,Stoddard Anne M.,Everhart James E.,

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.24370/fullpdf

Reference21 articles.

1. The history of the “natural history” of hepatitis C (1968-2009);Seeff;Liver International,2009

2. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients;Fattovich;Gastroenterology,1997

3. Compensated cirrhosis: natural history and prognostic factors;Gines;HEPATOLOGY,1987

4. Survival and prognostic indicators in compensated and decompensated cirrhosis;D'Amico;Dig Dis Sci,1986

5. Changes of laboratory variables with time in cirrhosis: prognostic and therapeutic significance;Christensen;HEPATOLOGY,1985

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Direct-Acting Antiviral Therapy for Patients with Chronic Hepatitis C Infection and Decompensated Cirrhosis;Digestive Diseases and Sciences;2024-04-05

2. Is it time for China to prioritize pan-genotypic regimens for treating patients with hepatitis C?;Cost Effectiveness and Resource Allocation;2024-02-06

3. Real-World Value of Direct-Acting Antivirals for Hepatitis C at Kaiser Permanente Southern California;The American Journal of Managed Care;2023-10-20

4. Liver disease progression in patients with alpha‐1 antitrypsin deficiency and protease inhibitor ZZ genotype with or without lung disease;Alimentary Pharmacology & Therapeutics;2023-09-17

5. Economic Impact of Universal Hepatitis C Virus Testing for Middle-Aged Adults Who Inject Drugs;American Journal of Preventive Medicine;2023-01